In Vitro Technologies is committed to providing essential products to the scientific and medical community, especially during the current, quickly changing circumstances caused by the corona virus (COVID-19) outbreak.
About Us
In Vitro Technologies Life Sciences division has a long history of supporting the Australian research community reaching back to 1958 and has developed a reputation for being one of the most dynamic and successful life science suppliers throughout Australia and New Zealand.
In Vitro Technologies are the premier supplier for cell biology and immunology research throughout Australia and New Zealand. Our range of cells, consumables, reagents, and laboratory equipment support your cell biology workflow in the fields of Cancer, Neuroscience, Immunology, Diabetes & Obesity, Cardiology, Pharmacology, and Drug Discovery. By partnering with world-class suppliers, In Vitro Technologies enables high quality, reproducible data, allowing researchers to accelerate discovery and publish high impact papers.
All news
Latest News
Dec 9, 2019
Nobel Prize winners leverage Seahorse XF Technology
In October of 2019, the Nobel Assembly announced the award of the 2019 Nobel Prize jointly to William G. Kaelin, Jr., Sir Peter J. Ratcliffe and Gregg L. Semenza in Physiology or Medicine. This award is to acknowledge their scientific discoveries of how cells sense and adapt to oxygen availability.
Nov 4, 2019
RNA expression like you’ve never seen it before
In Vitro Technologies are proud to announce two upcoming seminars detailing ACD Bio RNAscope® technology, a unique technology enabling RNA target expression analysis within intact cells and tissues with high sensitivity and specificity.
Oct 17, 2019
ATCC Launches First Portal of Whole-genome Sequences Based on Authenticated Biological Standards
ATCC launched its new ATCC Genome Portal, a publicly available database of reference-quality genome sequences matched to authenticated ATCC biological materials that will help researchers interpret and reproduce their results with confidence. The portal, which launched with an initial 250 genome sequences of widely used bacterial strains, delivers on ATCC’s Enhanced Authentication Initiative, a component of the first of five core pledges under the Incredible 2020 Initiative aimed at increasing reproducibility in biological research.
Katelyn Meier has been assisting me with an order for ATCC cell lines that I placed while I was at Monash University last year, and I wanted to shoot you an email to let you know what a fantastic help she has been! Katelyn has been rapidly communicating any updates to the orders, which allowed me to work out a plan to ensure there was someone available to receive the cells in a timely way for proper storage. I felt that she was consistently on the ball, and I received great customer service.
Michelle Audsley
RMIT
